1,527
Views
8
CrossRef citations to date
0
Altmetric
Article

An incoherent HIFU transducer for treatment of the medial branch nerve: Numerical study and in vivo validation

, , , , , , & show all
Pages 1219-1228 | Received 17 Apr 2020, Accepted 21 Sep 2020, Published online: 26 Oct 2020
 

Abstract

Background

Chronic back pain due to facet related degenerative changes affects 4-6 million patients a year in the United States. Patients refractory to conservative therapy may warrant targeted injections of steroids into the joint or percutaneous medial branch nerve denervation with radiofrequency ablation. We numerically tested a novel noninvasive high intensity focused ultrasound transducer to optimize nerve ablation near a bone-soft tissue interface.

Methods

A transducer with 4 elements operating in an incoherent mode was modeled numerically and tested pre-clinically under fluoroscopic guidance. After 6 lumbar medial branch nerve ablations were performed in 2 pigs, they were followed clinically for 1 week and then sacrificed for pathological evaluation.

Results

Simulations show that the acoustic spot size in water at 6 dB was 14mm axial x 1.6mm lateral and 52mm axial x 1.6mm lateral for coherent and incoherent modes, respectively. We measured the size of N = 6 lesions induced in vivo in a pig model and compared them to the size of the simulated thermal dose. The best match between the simulated and measured lesion size was found with a maximum absorption coefficient in the cortical bone adjusted to 30 dB/cm/MHz. This absorption was used to simulate clinical scenarios in humans to generate lesions with no potential side effects at 1000 and 1500 J.

Conclusion

The elongated spot obtained with the incoherent mode facilitates the targeting during fluoroscopic-guided medial branch nerve ablation.

Disclosure statement

AH and RA are the founders of FUSMobile. JFA is a member of the scientific advisory board of FUSMobile and holds ordinary options of the company. JC was paid as an advisor to FUSMobile. SDL holds shares and ordinary options in FUSMobile. JP and YS did not receive remuneration for contribution to this study but their institution, McGill University, did receive payment for participation in follow up studies. MG is involved in other research projects funded by FUSMobile.